p53 gene mutations in asbestos associated cancers

Biomedical and Environmental Sciences

Volumn 11, Issue 3, 1998, Pages 226-232

  Liu, Bing Ci ^a   Fu, De Chen ^a   Miao, Qing ^a   Wang, Hai Hua ^a   You, Bao Rong ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; DNA;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AMINO ACID SEQUENCE; ARTICLE; CHEMICALLY INDUCED DISORDER; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; LYMPHOMA; MESOTHELIOMA; MOLECULAR GENETICS; POINT MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AMINO ACID SEQUENCE; ASBESTOS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOMA; MESOTHELIOMA; MOLECULAR SEQUENCE DATA; POINT MUTATION;

EID: 0032152147     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Biggs, P. J., Warren, W., Venitt, S., and Stratton, M. R. (1993). Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 8, 275-283.
2. Chamberlain, M., Tarmy, E. M., Light, W. G., and Wei, E. T. (1977). The in vitro effects of mineral dust. Mutat. Res. 43, 159; 139-145.
3. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research 54, 4855-4878.
4. Harris, C. C. (1991). Chemical and physical carcinogenesis: Advances and perspectives for the 1990s. Cancer Res. 51, 5023-5044s.
5. Husgafvel-pursiainen, K. P., Hackman, P., Ridanpaa, M., Anttila, S., Karjalainen, A., Partanen, T., Taikina-aho, O., Heikkila, L., and Vainio, H. (1993). K-ras mutations in human adenocarcinoma of the lung: associated with smoking and occupational exposure to asbestos. Int. J. Cancer 53, 250-256.
6. Kim, J. W., Cho, Y. H., Kwon, D. J., Kim, T. E., Park, T. C., Lee, J. M., and Namkoong, S. E. (1995). Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma. Gynecologic Oncology 57, 199-204.
7. Kishimoto, Y., Murakami, Y., Shiraishi, M., Hayashi, K., and Sekiya, T. (1992). Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Research 52, 4799-4804.
8. Lohmann, D., Putz B., Reich, U., Bohm, J., Prauer, H., and Hofler, H. (1993). Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data. American Journal of Pathology 142(3), 907-915.
9. Pitot, H. C. (1990). Principles of carcinogenesis: chemical. In Cancer. Principles and Practice of Oncology (V. T. Devita, Jr. S. Hellman, and S. A. Rosenberg Eds. ), pp. 116-135. J. B. Lippincott Co. Philadelphia.
10. Prives, C. and Manfredi, J. J. (1993). The p53 tumor suppressor protein: meeting review. Genes & Development 7, 529-534.
11. Resnick, J. M., Cherwitz, D., Knapp, D., Uhlman, D., and Nichans, G. A. (1995). A microwave method that enhances detection of aberrant p53 expression in formalin-fixed, Paraffin-embedded tissues. Arch Pathol Lab Med. 119, 360-366.
12. Rotello, R. J., Lieberman, R. C., Purchio, A. F., and Gerschenson, L. E. (1991). Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA, 88, 3412-3415.
13. Susan, E., Goelz, Stanley R., Hamilton, and Bert Vogelstein. (1985). Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochemical and Biophysical Research Communications 130, 118-126.
14. US EPA (1988). Study of Asbestos-Containing Materials in Public Buildings, Report to the Congress, U. S. Environmental Protection Agency, Washington DC, p. 5.